Effects of Dexmedetomidine Administered Through Different Routes on Kidney Tissue in Rats with Spinal Cord Ischaemia–Reperfusion Injury

References

• Auerbach JD, Kean K, Milby AH, et al. Delayed postoperative neurologic deficits in spinal deformity surgery. Spine. 2016;41(3):E131–E138. doi:10.1097/BRS.0000000000001194
   PubMed Web of Science ®Google Scholar
• Bell MT, Puskas F, Smith PD, et al. Attenuation of spinal cord ischemia-reperfusion injury by specific α-2a receptor activation with dexmedetomidine. J Vasc Surg. 2012;56(5):1398–1402. doi:10.1016/j.jvs.2012.04.012
   PubMed Web of Science ®Google Scholar
• Fang B, Li X-Q, Bi B, et al. Dexmedetomidine attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia reperfusion injury in rats. Cell Physiol Biochem. 2015;36(1):373–383. doi:10.1159/000430107
   PubMedGoogle Scholar
• Liu M, Liang Y, Chigurupati S, et al. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol. 2008;19:1360–1370. doi:10.1681/ASN.2007080901
   PubMed Web of Science ®Google Scholar
• Tang C, Huang X, Kang F, et al. Intranasal dexmedetomidine on stress hormones, inflammatory markers, and postoperative analgesia after functional endoscopic sinus surgery. Mediators Inflamm. 2015;2015:939431. doi:10.1155/2015/939431
   PubMed Web of Science ®Google Scholar
• Tang C, Xia Z. Dexmedetomidine in perioperative acute pain management: a non-opioid adjuvant analgesic. J Pain Res. 2017;10:1899–1904. doi:10.2147/JPR.S139387
   PubMed Web of Science ®Google Scholar
• Balcı C, Akan M, Boztaş N, et al. Protective effects of dexmedetomidine and remote ischemic preconditioning on renal ischemia reperfusion injury in rats. Ulus Travma Acil Cerrahi Derg. 2017;23(4):279–286. doi:10.5505/tjtes.2016.49103
   PubMed Web of Science ®Google Scholar
• Liu Y, Sheng B, Wang S, Lu F, Zhen J, Chen W. Dexmedetomidine prevents acute kidney injury after adult cardiac surgery: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2018;18(1):7. doi:10.1186/s12871-018-0472-1
   PubMed Web of Science ®Google Scholar
• Ma D, Hossain M, Rajakumaraswamy N, et al. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol. 2004;502:87–97. doi:10.1016/j.ejphar.2004.08.044
   PubMed Web of Science ®Google Scholar
• Kuzgun Ö, Özkardeşler S, Özbilgin Ş, et al. Effects of dexmedetomidine on renal ischaemia reperfusion injury in streptozotocin-induced diabetic rats. Turk J Anaesthesiol Reanim. 2018;46(6):462–469. doi:10.5152/TJAR.2018.62592
   PubMed Web of Science ®Google Scholar
• Bostan H, Kalkan Y, Tomak Y, et al. Reversal of rocuronium-induced neuromuscular block with sugammadex and resulting histopathological effects in rat kidneys. Ren Fail. 2011;33(10):1019–1024. doi:10.3109/0886022X.2011.618972
   PubMed Web of Science ®Google Scholar
• Erbatur ME, Sezen ŞC, Bayraktar AC, Arslan M, Kavutçu M, Aydın ME. Effects of dexmedetomidine on renal tissue after lower limb ischemia reperfusion injury in streptozotocin induced diabetic rats. Libyan J Med. 2017;12(1):1270021. doi:10.1080/19932820.2017.1270021
   PubMed Web of Science ®Google Scholar
• Durak I, Canbolat O, Kavutcu M, Ozturk HS, Yurtarslani Z. Activities of total, cytoplasmic, and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Lab Anal. 1996;10(1):17–20. doi:10.1002/(SICI)1098-2825(1996)10:1<17::AID-JCLA4>3.0.CO;2-I
   PubMed Web of Science ®Google Scholar
• Van Ye TM, Roza AM, Pieper GM, Henderson J, Johnson JP, Adams MB. Inhibition of intestinal lipid peroxidation does not minimize morphological damage. J Surg Res. 1993;55:553–558. doi:10.1006/jsre.1993.1183
   PubMed Web of Science ®Google Scholar
• Lowry O, Rosenbraugh N, Farr L, Randall R. Protein measurement with folin phenol reagent. J Biol Chem. 1951;182:265–275. doi:10.1016/S0021-9258(19)52451-6
   Google Scholar
• Wan IY, Angelini GD, Bryan AJ, Ryder I, Underwood MJ. Prevention of spinal cord ischaemia during descending thoracic and thoracoabdominal aortic surgery. Eur J Cardiothorac Surg. 2001;19:203–213. doi:10.1016/S1010-7940(00)00646-1
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123:92–100. doi:10.1172/JCI62874
   PubMed Web of Science ®Google Scholar
• Yan HF, Tuo QZ, Yin QZ, Lei P. The pathological role of ferroptosis in ischemia/reperfusion-related injury. Zool Res. 2020;41(3):220–230. doi:10.24272/j.issn.2095-8137.2020.042
   PubMed Web of Science ®Google Scholar
• Misthos P, Katsaragakis S, Theodorou D, et al. The degree of oxidative stress is associated with majör adverse effects after lung resection: a prospective study. Eur J Cardiothorac Surg. 2006;29:591–595. doi:10.1016/j.ejcts.2005.12.027
   PubMed Web of Science ®Google Scholar
• Farmer EE, Mueller MJ. ROS-mediated lipid peroxidation and RES-activated signaling. Annu Rev Plant Biol. 2013;64:429–450. doi:10.1146/annurev-arplant-050312-120132
   PubMed Web of Science ®Google Scholar
• Klune JR, Tsung A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. Surg Clin North Am. 2001;90:665–677. doi:10.1016/j.suc.2010.04.003
   Web of Science ®Google Scholar
• Park SW, Kim M, Brown KM, D’Agati VD, Lee HT. Paneth cell-derived interleukin-17A causes multiorgan dysfunction after hepatic ischemia and reperfusion injury. Hepatology. 2011;53(5):1662–1675. doi:10.1002/hep.24253
   PubMed Web of Science ®Google Scholar
• Nishikata R, Kato N, Hiraiwa K. Oxidative stress may be involved in distant organ failure in tourniquet shock model mice. Leg Med. 2014;16(2):70–75. doi:10.1016/j.legalmed.2013.11.004
   PubMed Web of Science ®Google Scholar
• Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15(3):R153. doi:10.1186/cc10283
   PubMed Web of Science ®Google Scholar
• Fröhlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013;34(23):1714–1722. doi:10.1093/eurheartj/eht090
   PubMed Web of Science ®Google Scholar
• Heusch G, Gersh BJ. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 2017;38(11):774–784. doi:10.1093/eurheartj/ehw224
   PubMed Web of Science ®Google Scholar
• Tang C, Hu Y, Gao J, et al. Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sci. 2020;257:118004. doi:10.1016/j.lfs.2020.118004
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121(11):4210–4221. doi:10.1172/JCI45161
   PubMed Web of Science ®Google Scholar
• An M, Zhang T, Deni W, Hou L, Jin K, Jin K. Dexmedetomidine inhibits microglial activation through SNHG14/HMGB1 pathway in spinal cord ischemia-reperfusion injury mice. Int J Neurosci. 2022;132(1):77–88. doi:10.1080/00207454.2020.1835901
   PubMed Web of Science ®Google Scholar
• Singh AP, Junemann A, Muthuraman A, et al. Animal models of acute renal failure. Pharmacol Rep. 2012;64(1):31–44. doi:10.1016/S1734-1140(12)70728-4
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37(2):112–119. doi:10.1016/j.clinbiochem.2003.10.014
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–1111. doi:10.1016/j.clinbiochem.2005.08.008
   PubMed Web of Science ®Google Scholar
• Halder T, Upadhyaya G, Basak C, Das A, Chakraborty C, Ray S. Dehydrins impart protection against oxidative stress in transgenic tobacco plants. Front Plant Sci. 2018;14(9):136. doi:10.3389/fpls.2018.00136
   Web of Science ®Google Scholar
• Bao N, Dai D. Dexmedetomidine protects against ischemia and reperfusion-induced kidney injury in rats. Mediators Inflamm. 2020;2020:2120971. doi:10.1155/2020/2120971
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Mohammadi MT, Sahebkar A. PPAR-α agonist improves hyperglycemia-induced oxidative stress in pancreatic cells by potentiating antioxidant defense system. Drug Res. 2018;68(6):355–360. doi:10.1055/s-0043-121143
   Web of Science ®Google Scholar
• Kumar AB, Suneja M, Riou B. Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology. 2011;114(4):964–970. doi:10.1097/ALN.0b013e318210f86a
   PubMed Web of Science ®Google Scholar
• Kocoglu H, Karaaslan K, Gonca E, Bozdogan O, Gulcu N. Preconditionin effects of dexmedetomidine on myocardial ischemia/reperfusion injury in rats. Curr Ther Res Clin Exp. 2008;69(2):150–158. doi:10.1016/j.curtheres.2008.04.003
   PubMed Web of Science ®Google Scholar
• Kocoglu H, Ozturk H, Ozturk H, Yilmaz F, Gulcu N. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study. Ren Fail. 2009;31(1):70–74. doi:10.1080/08860220802546487
   PubMed Web of Science ®Google Scholar
• Yu X, Chi X, Wu S, et al. Dexmedetomidine pretreatment attenuates kidney injury and oxidative stress during orthotopic autologous liver transplantation in rats. Oxid Med Cell Longev. 2016;2016:4675817. doi:10.1155/2016/4675817
   PubMed Web of Science ®Google Scholar
• Bell MT, Puskas F, Bennett DT, et al. Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion. J Thorac Cardiovasc Surg. 2014;147(1):500–506. doi:10.1016/j.jtcvs.2013.07.043
   PubMed Web of Science ®Google Scholar
• Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol. 2008;21(4):457–461. doi:10.1097/ACO.0b013e328305e3ef
   PubMed Web of Science ®Google Scholar
• Lai YC, Tsai PS, Huang CJ. Effects of dexmedetomidine on regulating endotoxin-induced up-regulation of inflammatory molecules in murine macrophages. J Surg Res. 2009;154(2):212–219. doi:10.1016/j.jss.2008.07.010
   PubMed Web of Science ®Google Scholar
• Si YN, Bao HG, Zhang Y, et al. Renoprotective effects and mechanism of dexmedetomidine on renal ischemia/reperfusion injury in rats. J Clin Anesthesiol. 2013;29:261–264.
   Google Scholar
• Xu Z, Wang D, Zhou Z, et al. Dexmedetomidine attenuates renal and myocardial ischemia/reperfusion injury in a dose-dependent manner by inhibiting inflammatory response. Ann Clin Lab Sci. 2019;49(1):31–35.
   PubMed Web of Science ®Google Scholar